5th International Summer School Teaming up for cardiovascular risk reduction – an integrated approach

Cardiovascular disease (CVD) caused 1 in 3 deaths globally in 2023 . In total, 19.2 million people died in 2023 due to CVD, a 6.1 million increase since 1990. Population growth, aging and increased exposure to modifiable risk factors drove CVD burden around the world. Recognized as a major worldwide health emergency, cardiometabolic disorders continue to rise, impacting on health systems and requiring more effective and targeted
strategies. Pathophysiology, pharmacology and therapeutics need to team up for effective CVD risk reduction. Pharmacological research has contributed much to attacking diseases through the development of drugs such
as GLP 1 receptor agonists, inhibitors of renin angiotensin aldosterone system and statins. However, further efforts towards developing better drugs and targeting unmet medical needs are still needed. The learning objective is two fold:
1) To provide next generation physicians with an integrated view of research and clinical approaches to prevent and treat CVD;

2) To foster exchange and networking between medical student from several European countries. This will hopefully be the fifth in a series of educational events to build relations among international medical students for years to come.